Fig. 3.
Fig. 3. Kaplan-Meier actuarial probability of chronic GVHD in patients with CML in first chronic phase treated with nonmyeloablative stem cell transplantation (NST).

Kaplan-Meier actuarial probability of chronic GVHD in patients with CML in first chronic phase treated with nonmyeloablative stem cell transplantation (NST).

Close Modal

or Create an Account

Close Modal
Close Modal